Similar Items: Producción y evaluación de antígenos recombinantes para el diagnóstico serológico y la generación de vacunas para el control de la anaplasmosis bovina
- Producción y evaluación de antígenos recombinantes para el diagnóstico serológico y la generación de vacunas para el control de la anaplasmosis bovina
- Development and evaluation of a double-antigen sandwich ELISA to identify Anaplasma marginale–infected and A. centrale–vaccinated cattle
- Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale
- Evaluación de la actividad inmunogénica de una vacuna para profilaxis de la anaplasmosis bovina
- Development of a novel fusion protein with Anaplasma marginale and A. centrale MSP5 improved performance of Anaplasma antibody detection by cELISA in infected and vaccinated cattle
- Development and field evaluation of an ELISA to differentiate Anaplasma marginale–infected from A. centrale–vaccinated cattle
Author: Primo, María Evangelina (directora)
Author: Sarli, Macarena
- Relationship between pharmacokinetics of fluazuron and its efficacy for controlling Rhipicephalus microplus: A comprehensive evaluation of tick drug uptake
- Development and evaluation of a TaqMan® real-time PCR assay for species-specific detection of Ehrlichia canis
- Fluazuron efficacy against Rhipicephalus microplus (Acari: Ixodidae) in cattle: Systemic exposure and pattern of tick drug uptake
- Influence of the cattle body weight estimation for drug dosing on the pharmacokinetic and efficacy of ivermectin against Rhipicephalus (Boophilus) microplus
- Analysis of sequence variations in the GABA gated chloride gene associated with resistance to fipronil in Rhipicephalus (Boophilus) microplus ticks from Argentina
- Successive treatments with ivermectin (3.15%) to control the tick Rhipicephalus (Boophilus) microplus in cattle: Pharmacokinetic and efficacy assessment